SB 564

Senate·20th Congress·Filed Jul 14, 2025

Counterfeit Pharmaceutical Products Prevention Act

An Act Strengthening the Regulatory System in the Country to Prevent Counterfeit Pharmaceutical Products, Declaring Large-Scale Counterfeiting Activities as an Offense Involving Economic Sabotage, Providing for the Prohibitions and Penalties for Violations Thereof, and Repealing for the Purpose Republic Act No. 8203 Otherwise Known as the 'special Law on Counterfeit Drugs'

In plain language

The Counterfeit Pharmaceutical Products Prevention Act would make any making, moving, selling or even possessing fake medicines a crime, treat large‑scale operations as “economic sabotage,” and give the FDA new powers to inspect, seize, and punish offenders.

HealthJustice and JudiciaryPublic Order and Safety

Automated summary by BatasWatch. It may miss nuance — read the bill text before citing it.

Author · Senator

Risa Hontiveros-Baraquel
SenatorAna Theresia "Risa" Hontiveros-Baraquel
Receipts →

Subjects

Economic SabotagePharmaceutical ProductsCounterfeit Medicines

Official sources

Similar in what they’d do, filed by any lawmaker.

HB 5561· Filed Oct 14, 2025
An Act Strengthening the Regulatory System in the Country to Combat Counterfeit Pharmaceutical Products, Declaring the Manufacture, Importation, Distribution, Sale or Offer for Sale, or Possession of Counterfeit Pharmaceutical Products as an Offense Involving Economic Sabotage, Providing Penalties for Violations Thereof, Repealing for the Purpose Republic Act No. 8203, Otherwise Known as the "Special Law on Counterfeit Drugs"
Pending with the Committee on HEALTH since 2025-11-11Rep. Keith Micah "Atty. Mike" D.l. Tan
HB 7538· Filed Feb 2, 2026
An Act Strengthening the National Regulatory Framework to Prevent and Eliminate Counterfeit Pharmaceutical Products, Declaring Large-Scale Counterfeiting as an Act of Economic Sabotage, Mandating Stiffer Penalties, and Repealing Republic Act No. 8203
Pending with the Committee on HEALTH since 2026-02-04Rep. Jocelyn P. Tulfo +1
HB 8896· Filed Apr 21, 2026
An Act Strengthening the Regulatory System in the Country to Combat Counterfeit Pharmaceutical Products, Declaring the Manufacture, Importation, Distribution, Sale or Offer for Sale, or Possession of Counterfeit Pharmaceutical Products as an Offense Involving Economic Sabotage, Providing Penalties for Violations Thereof, Repealing for the Purpose Republic Act No. 8203, Otherwise Known as the "Special Law on Counterfeit Drugs"
Pending with the Committee on HEALTH since 2026-05-05Rep. Ferdinand Martin G. Romualdez +3
HB 4702· Filed Sep 18, 2025
An Act Strengthening the Powers and Functions of the Intellectual Property Office of the Philippines, Amending for the Purpose Republic Act No. 8293, as Amended, Otherwise Known as the �intellectual Property Code of the Philippines�
Pending with the Committee on TRADE AND INDUSTRY since 2025-09-24Rep. Adrian E. Salceda
HB 10910· Filed Aug 24, 2026
An Act Expanding Access to Genuine, Safe, and Affordable Medicines in Every Community by Recognizing and Regulating Telepharmacy as a Mode of Pharmaceutical Supervision, Modernizing the Supervision of Retail Outlets for Non-Prescription Drugs, Authorizing Automated Over-The- Counter Dispensing Machines Under Full Traceability, Establishing the Certified Pharmacy Assistant Program, Strengthening the Campaign Against Counterfeit Medicines, Protecting and Expanding the Pharmacy Profession, and Appropriating Funds Therefor
Pending with the Committee on HEALTH since 2026-08-26Rep. Elmer V. Catulpos

Spot something wrong?

SBN-564 · Sources: BetterGov Open Congress, BatasWatch